Where Does Cara Therapeutics Inc (CARA) Stock Fall in the Biotechnology Field After It Is Down -5.41% This Week?

Cara Therapeutics Inc (CARA) is around the bottom of the Biotechnology industry according to InvestorsObserver. CARA received an overall rating of 34, which means that it scores higher than 34 percent of all stocks. Cara Therapeutics Inc also achieved a score of 23 in the Biotechnology industry, putting it above 23 percent of Biotechnology stocks. Biotechnology is ranked 43 out of the 148 industries.

CARA has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on CARA!

See Full CARA Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 34 means the stock is more attractive than 34 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Cara Therapeutics Inc Stock Today?

Cara Therapeutics Inc (CARA) stock is trading at $1.05 as of 12:25 PM on Thursday, Nov 16, a drop of -$0.07, or -6.21% from the previous closing price of $1.12. The stock has traded between $1.04 and $1.16 so far today. Volume today is light. So far 280,417 shares have traded compared to average volume of 448,283 shares. Click Here to get the full Stock Report for Cara Therapeutics Inc stock.